Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy ® (Tegomil Fumarate) in Germany

Tiefenbacher Group and Neuraxpharm announce the launch of Riulvy® (Tegomil Fumarate) in GermanyAt Tiefenbacher Group, we are deeply committed to developing and delivering high-quality, value-added pharmaceuticals that improve the lives of patients worldwide. In collaboration with our trusted partner Neuraxpharm we are proud to announce the successful launch of Riulvy ® (Tegomil Fumarate) 174 mg […]

Tiefenbacher New Market Launch: Buprenorphine Patches in South Africa

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in South Africa. We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. That’s why we are thrilled to share that we have successfully prepared the launch of the generic version […]

Tiefenbacher Group about affordable medicines

Why are affordable medicines so important for healthcare?Did you know that affordable (generic) medicines represent the majority of treatments in Europe, accounting for 70% of the treatment volume and 19% of the market value in 2023? They play a crucial role in ensuring patient well-being and public health by providing safe, effective, and affordable treatments. […]

Tiefenbacher Group celebrates World Hypertension Day

“Measure Your Blood Pressure Accurately, Control It, Live Longer!”Last Saturday was World Hypertension Day, and at Tiefenbacher Group, we’re joining the global movement to raise awareness about high blood pressure and the importance of accurate measurement. This year’s theme: “Measure Your Blood Pressure Accurately, Control It, Live Longer!” High blood pressure is the leading modifiable […]

Tiefenbacher Pharmaceuticals Launch: Varenicline in UK

Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the United Kingdom We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available and affordable for patients all around the world. That´s why we are thrilled to share that we have successfully prepared the launch of Varenicline in the UnitedKingdom! WHO has added Varenicline to the […]

Tiefenbacher Pharmaceuticals New Market Launch: Amifampridine

Tiefenbacher Pharmaceuticals Successfully Prepares the Launch of Amifampridine Across Europe At Tiefenbacher Pharmaceuticals, we are deeply committed to making high-quality, life-changing medications affordable and accessible to patients worldwide, regardless of, nationality, or income. That’s why we are excited to share that we have successfully prepared the launch of Amifampridine Tablets 10mg. This is the first generic […]

Tiefenbacher Pharmaceuticals New Market Launch: Ezetimibe/Atorvastatin

Tiefenbacher Pharmaceuticals successfully prepares the launch of the generic version of Ezetimibe/Atorvastatin across the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared […]

Tiefenbacher Pharmaceuticals First to Market Launch: Varenicline in Europe

Tiefenbacher Pharmaceuticals successfully prepares the launch of Varenicline in the European Union We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available and affordable for patients all around the world. That´s why we are thrilled to share that we have successfully prepared the launch of the only available Varenicline containing product in Europe. WHO has […]

Tiefenbacher New Market Launch: Buprenorphine in Australia

Tiefenbacher Pharmaceuticals successfully prepared the launch of the analgesic Buprenorphine as Transdermal Patch in Australia.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled […]

Tiefenbacher Pharmaceuticals New Market Launch: Apremilast (Psoriasis)

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the psoriasis medication Apremilast in CanadaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are excited to share that we have successfully prepared the launch of the generic version of Apremilast […]

Tiefenbacher Pharmaceuticals New Market Launch: Abiraterone for prostate cancer

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launces generic version of the prostate cancer medicines Abiraterone and the value-added product Abiraterone/PrednisoloneWe at Tiefenbacher Pharmaceuticals aim to improve peoples´ lives around the world by making medicines better affordable, better available, and better than before! That´s why we are excited to share that we have successfully prepared the […]

TIEFENBACHER GROUP OPENS NEW SITE FOR HIGHLY POTENT DRUGS IN INDIA

TIEFENBACHER GROUP opens new site for highly potent drugs in India – we continuously expand in novel technologies and capabilities to improve quality and boost productivity of better healthcareTiefenbacher Group is excited to announce the ceremonious opening of our new highly potent drug laboratory in Hyderabad, India. The completion of the new building is the […]